IMF Videos Search Content For Care Partner (57) Patient (55) Healthcare Provider (19) Healthcare Professional (18) Series - Any - ASCO/EHA (2) ASH (14) Ask Dr. Durie (40) Black Swan Research Initiative (1) Facebook Live (3) Living Well with Myeloma (1) Myeloma in a Minute (1) Patient & Family Webinar (1) Q&A (7) Topics Clinical Trials (186) Financial Considerations (15) Frontline Therapy (84) Health Equity (34) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (72) Lifestyle (47) Mental & Emotional Health (29) Myeloma 101 (59) Myeloma in the News (8) Public Policy & Advocacy (17) Q&A's (43) Recorded Seminars & Workshops (15) Recorded Webinars (24) Relapse/Refractory Myeloma (138) Research Updates (194) Symptom Management (115) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (14) High-Risk Myeloma (12) High-risk Smoldering Myeloma (14) Late Relapse (4–6 Lines of Therapy) (12) MGUS (26) Newly Diagnosed (Pre-Treatment or First Treatment) (23) Smoldering Myeloma (31) Types of Therapy Immunomodulatory drugs (IMiDs) (10) Immunotherapies (CAR T; BiTE, etc.) (11) Monoclonal antibodies (9) Proteasome inhibitors (7) Stem cell transplant (9) Steroids (4) Supportive Care (21) Year Published 2026 (6) 2025 (4) 2024 (9) 2023 (8) 2022 (10) 2021 (5) 2020 (4) 2019 (9) 2018 (1) 2017 (8) 2016 (4) 2015 (4) Trusted Voices Dr. Brian GM Durie (36) Dr. Joseph Mikhael (8) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (5) Dr. Sigurður Kristinsson (2) Dr. María-Victoria Mateos (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance Screening for Monoclonal Gammopathy of Undetermined Significance: First Results from the iStopMM Study January 26, 2022 ASH Defining New Reference Intervals for Serum Free Light Chains in Individuals with Reduced Kidney Function: Results of the Population- Based on iStopMM Study December 15, 2021 ASH Assessment of Treatment Response By Ife, Next Generation Flow Cytometry and Mass Spectrometry Coupled with Liquid Chromatography in the GEM2012MENOS65 Clinical Trial December 13, 2021 ASH How important are the four iStopMM abstracts being presented at ASH for myeloma patients? December 8, 2021 Ask Dr. Durie When a myeloma patient’s kidney creatinine levels increase, does this indicate a relapse? September 8, 2021 Ask Dr. Durie How does the M-spike correlate to the amount of myeloma protein in the body? May 4, 2021 Ask Dr. Durie What should myeloma patients do when a low level of myeloma protein remains detectable? December 16, 2020 Ask Dr. Durie Do myeloma patients who are responding well to their treatment need to track potential bone disease? October 28, 2020 Ask Dr. Durie Do fractures resulting from a fall indicate myeloma progression? February 13, 2020 Ask Dr. Durie Should FISH testing be done at relapse? January 23, 2020 Ask Dr. Durie Can bone lesions progress even when all other tests look good? December 5, 2019 Ask Dr. Durie If the myeloma protein levels stay the same (or only drops slightly) with one cycle of treatment, should you switch to a different therapy? June 27, 2019 Ask Dr. Durie Load More
